THE ROLE OF PARATHYROID HORMONE-RELATED PROTEIN IN PATHOGENESIS OF DISORDERS OF BLADDER CONTRACTILE FUNCTION

Aim. Based on the analysis of the scientific literature sources, the authors aimed to summarize and present the existing information about the role of parathyroid hormone-related protein (PTHrP) in pathogenesis of disorders of bladder contractile function.

Materials and methods. Analysis of literature in databases Google Scholar, Scopus, Web of Scence, PabMed for the whole time period of studying the stated problem.

Results. In the recent years, one can observe a growing interest to dysfunction of bladder with insuffi contractile activity of detrusor. The low level activity of bladder can be often observed, while its diagnostics and treatment remain problematic. The existing ideas about the role of parathyroid hormone-related protein (PTHrP) in regulation of bladder’s functional condition are based on the results of few and mostly experimental research studies. It is proved that PTHrP secretion is induced in bladder as a result of bladder stretching, and prevents spontaneous contraction of detrusor’s smooth muscles, which has PTH/PTHrPreceptors, and also reduces contraction amplitude of bladder. It was stated that increased PTHrP secretion in response to the stretching smooth muscles is a part of autocrine effect, relaxing the bladder during its fi The existing scientifi data show that PTHrP is a unique endogenous detrusor relaxant, which functions by means of PTH/PTHrP-receptors located in bladder. It is assumed that PTHrP can also have a paracrine effect on vessels that regulate the blood fl bladder fi or can change neural activity. Thus, PTHrP is a powerful endogenous relaxant of bladder contraction, while autocrine or paracrine mechanisms of this effect are physiologically relevant processes happening in bladder. It is assumed that disturbed binding PTHrP with its receptor can be part ofpathogenesis of bladder disorders. In our opinion, the infl of chronic high PTHrP level in blood fl on the detrusor muscle structures can be also considered as one of the reasons that cause functional insuffi of bladder. This assumption is based on comparison of the PTHrP-effects on the bladder functional condition, presented in the experiment, as well as in the few clinical studies. Direct infl targeting the interaction of PTHrP with its specifi PTH/PTHrP-receptor is considered as a potential therapeutic approach to treat pathological conditions related to disorder of bladder contractile function.

Conclusion. The literature survey covers general ideas about functional insufficiency of bladder, as well as information about the role of PTHrP in its development. The studied problem is rather relevant and frequent in the population, and besides being seen as a urological pathology, it is associated with a considerable reduction of the quality of life for patients. More detailed clinical studies will let us specify the diagnostics criteria of this syndrome and develop the schemes for pathogenetic therapy.

1. Hara M., Liu Y.M., Zhen L.C. et al. Positive chronotropic actions of parathyroid hormone and parathyroid hormone-related peptide are associated with increases in the current, I(f), and the slope of the pacemaker potential. Circulation. 1997; 96: 3704-3709.

2. Yamamoto M., Harm S.C., Grasser W.A., Thiede M.A. Parathyroid hormone-related protein in the rat urinary bladder: a smooth muscle relaxant produced locally in response to mechanical stretch. ProcNatlAcadSci USA. 1992; 89(12): 5326-5330.

3. Daifotis A.G., Weir E.C., Dreyer B.E., Broadus AE. Stretch-induced parathyroid hormone-related peptide gene expression in the rat uterus. J Biol Chem. 1992; 267(33): 23455-8.

4. Nishikawa N., Kanematsu A., Negoro H. et al. PTHrP Is Endogenous Relaxant for Spontaneous Smooth Muscle Contraction in Urinary Bladder of Female Rat. Endocrinology. 2013; 154(6): 2058-2068. DOI: 10.1210/en.2012-2142.

5. Steers W.D., Broder S.R., Persson K. et al. Mechanical stretch increases secretion of parathyroid hormone-related protein by cultured bladder smooth muscle cells. J Urol. 1998; 160(3 Pt 1): 908-12. DOI.org/10.1016/S0022-5347(01)62831-3.

6. Lee K, Mitsui R, Kajioka S, Naito S, Hashitani H (2016) Role of PTHrP and sensory nerve peptides in regulating the contractility of muscularis mucosae and detrusor smooth muscle in the guinea-pig bladder. The Journal of Urology. 2016; 196(4): 1287-1294. DOI: 10.1016/j.juro.2016.04.082.

7. Imamura M., Kanematsu A., Yamamoto S. et al. Basic fibroblast growth factor modulates proliferation and collagen expression in urinary bladder smooth muscle cells. Am J Physiol Renal Physiol. 2007; 293(4): F1007-F1017. DOI.org/10.1152/ajprenal.00107.2007.

8. Imamura M., Negoro H., Kanematsu A. et al. Basic fibroblast growth factor causes urinary bladder overactivity through gap junction generation in the smooth muscle. Am J Physiol Renal Physiol. 2009; 297(1): F46-54. DOI:10.1152/ajprenal.90207.2008.

9. Okutsu H., Matsumoto S., Ohtake A. et al. Effect of tamsulosin on bladder blood flow and bladder function in a rat model of bladder over distention/emptying induced bladder overactivity. J Urol. 2011; 186(6): 2470-7. DOI.org/10.1016/j.juro.2011.07.085.

10. Adam R.M., Eaton S.H., Estrada C. et al. Mechanical stretch is a highly selective regulator of gene expression in human bladder smooth muscle cells. Physiol. Genomics. 2004; 20(1): 36-44. DOI: 10.1152/physiolgenomics.00181.2004.

11. Brading A.F. A myogenic basis for the overactive bladder. Urology. 1997; 50(6A Suppl): 57-67; discussion 68-73.

12. Saito M., Shimizu S., Kinoshita Y. et al. Bladder dysfunction after acute urinary retention in the rats: a novel over active bladder model. Mol Cell Biochem. 2010; 333(1-2): 109-14. DOI: 10,1007/s11010-009-0210-6.

13. Yang R., Amir J., Liu H., Chaqour B. Mechanical strain activates a program of genes functionally involved in paracrine signaling of angiogenesis. Physiol. Genomics. 2008; 36(1): 1-14. DOI: 10.1152/physiolgenomics.90291.2008.

14. Griffiths D.J. Assessment of detrusor contraction strength or contractility. / Neurourol. Urodyn. 1991; 10: 1-18. DOI: 10.1002/nau.1930100102.

15. Hashitani H., Brading A.F., Suzuki H. Correlation between spontaneous electrical, calcium and mechanical activity in detrusor smooth muscle of the guinea-pig bladder. Br J Pharmacol. 2004; 141(1): 183-93. DOI: 10.1038/sj.bjp.0705602.

16. IkedaY., Fry C., Hayashi F., Stolz D. et al. Role of gap junctions in spontaneous activity of the rat bladder. Am J Physiol. Renal Physiol. 2007; 293(4): F1018-25. DOI: 10.1152/ajprenal.00183.2007.

17. McCarthy C.J., Zabbarova I.V., Brumovsky P.R. et al. Spontaneous contractions evoke afferent nerve firing in mouse bladders with detrusor overactivity. J Urol. 2009; 181(3): 1459-66. DOI: 10.1016/j.juro.2008.10.139.

18. Meng E., Young J.S., Brading A.F. Spontaneous activity of mouse detrusor smooth muscle and the effects of the urothelium. Neurourol. Urodyn. 2008; 27(1): 79-87. DOI: 10.1002/nau.20456.

19. Perez-Martinez F.C., Juan Y.S., Lin W.Y. et al. Expression of parathyroid hormone-related protein in the partially obstructed and reversed rabbit bladder. Int. Urol. Nephrol. 2009; 41(3): 505-11. DOI: 10.1186/1471-2490-15-2.

20. Kitazawa S., Kitazawa R., Fukase M. et al. Immunohistochemical evaluation of parathyroid hormone-related protein (PTHrP) in the uterine cervix. Int. J Cancer. 1992; 50: 731-735.

21. Vaidyanathan S., McCreavy D.T., McDicken I.W. et al. Immunohistochemical study of parathyroid hormone-related protein in vesical transitional epithelium of patients with spinal cord injury. Spinal cord. 1999; 37(11): 760-764.

22. Vaidyanathan S., McDicken I.W., Mansour P. et al. Parathyroid hormone-related protein (1-34) and urothelialredifferentiation in the neuropathic urinary bladder. Spinal Cord. 2000; 38(9): 546-551.

23. Ozkan B, Demirkesen O, Durak H, Uygun N, Ismailoglu V, Cetinel B: Which factors predict upper urinary tract deterioration in overactive neurogenic bladder dysfunction? Urology, 2005; 66(1): 99-104. DOI.org/10.1016/j.urology.2005.02.009.

24. Nishikawa N., Yago R., Yamazaki Y. et al. Expression of parathyroid hormone/parathyroid hormone-related peptide receptor 1 in normal and diseased bladder detrusor muscles: a clinico-pathological study. BMC Urol. 2015; 15(1): 2.Published online. 2015 Jan 21. DOI: 10.1186/1471-2490-15-2.

25. Smith P.P., Birder L.A., Abrams P. et al. Detrusor underactivity and the underactive bladder: Symptoms, function, cause-what do we mean? ICI-RS thinktank. 2014. Neurourol. Urodyn. 2016; 35(2): 312-7. DOI: 10.1002/nau.22807.

26. Ahmed A., Farhan B., Vernez S., Ghoniem G.M. The challenges in the diagnosis of detrusor underactivity in clinical practice: A mini-review. Arab Journal of Urology. 2016; 14: 223-227. DOI: 10.1016/j.aju.2016.06.005.

27. Osman N.I., Chapple C.R., Abrams P., et al. Detrusor underactivity and the underactive bladder: a new clinical entity? A review of current terminology, definitions, epidemiology, aetiology, and diagnosis. Eur Urol. 2014; 65: 389-98. DOI: 10.1016/j.eururo.2013.10.015.

28. Van Koeveringe G.A., Vahabi B, Andersson KE et al. Detrusor underactivity: a plea for new approaches to a common bladder dysfunction. Neurourol. Urodyn. 2011; 30: 723-8. DOI: 10.1002/nau.21097.

29. Van Koeveringe GA, Rademakers KL, Birder LA, et al. Detrusor underactivity: pathophysiological considerations, models and proposals for future research. ICI-RS 2013. Neurourol. Urodyn. 2014; 33: 591-6. DOI: 10.1002 / nau.22590.

30. Abrams P., Cardozo L., Fall M., et al. The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society. Neurourol. Urodyn. 2002; 21: 167-78. DOI: 10.1002/nau.10052.

31. Abrams P. Bladder outlet obstruction index, bladder contractility index and bladder voiding efficiency: three simple indices to define bladder voiding function. BJU Int. 1999; 84: 14-5. DOI: 10.1046/j.1464-410x.1999.00121.x.

32. Hoag N., Gani J. Underactive Bladder: Clinical Features, Urodynamic Parameters, and Treatment. International Neurourology Journal. 2015; 19(3): 185-189. DOI: 10.5213/inj.2015.19.3.185.

33. Chang Y.H., Siu J.J., Hsiao P.J., Chang C.H., Chou E.C. Review of underactive bladder. J Formos Med Assoc. 2018; 117(3): 178-184. DOI: 10.1016/j.jfma.2017.09.006.

34. Uren A.D., Cotterill N., Harding C. et al. Qualitative Exploration of the Patient Experience of Underactive Bladder. Eur Urol. 2017; 72(3): 402-407. DOI: 10.1016/j.eururo.2017.03.045.

35. Miyazato M., Yoshimura N., Chancellor M.B. The other bladder syndrome: underactive bladder. Rev Urol. 2013; 15: 11-22.

36. Rigby D.Underactive bladder syndrome. NursStand. 2005; 19: 57-64.

37. Chapple C.R., Osman N.I., Birder L. et al. The Underactive Bladder: A New Clinical Concept? Eur Urol. 2015; 68: 351-353. DOI: 10.1016/j.eururo.2015.02.030.

38. Chapple C.R., Osman N.I. Crystallizing the Definition of Underactive Bladder Syndrome, a Common but Under-recognized Clinical Entity. Lower Urinary Tract Symptoms. 2015; 7: 71-76. DOI: 10.1111/luts.12101.

39. Chung E. Underactive bladder and detrusor underactivity: a review of pathophysiology and management strategies for this poorly understood bladder syndrome. Curr Bladder Dysfunct Rep. 2014; 9: 250-253. DOI: 10.1007/s11884-014-0248-5.

40. Taylor J.A., Kuchel G.A. Detrusor underactivity: clinical features and pathogenesis of an underdiagnosed geriatric condition. J Am Geriatr. Soc. 2006; 54: 1920-1932. DOI: 10.1111/j.1532-5415.2006.00917.x.

41. Andersson K.E., Nomiya M. Chronic pelvic ischemia: contribution to the pathogenesis of lower urinary tract symptoms (LUTS) – A new target for pharmacological treatment? LUTS. 2015; 7: 1-8. DOI: 10.1111/luts.12084.

42. Chancellor M.B., Diokno A., CURE-UAB: hedding light on the underactive bladder syndrome. IntUrolNephrol. 2014; 46(Suppl 1): S1. DOI: 10.1007/s11255-014-0789-8.

43. Yoshida M, Yamaguchi O. Detrusor underactivity: the current concept of the pathophysiology. LUTS. 2014; 6: 131-7. DOI: 10.1111/luts.12070.